Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society
- PMID: 32067815
- DOI: 10.1016/j.ygyno.2020.01.035
Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society
Conflict of interest statement
Declaration of competing interest Dr. Pinkerton reports non-financial support from Pfizer, grants from Therapeutics MD, non-financial support from Amag, outside the submitted work; none in past 12 months. Drs. Sinno, Febbraro, Jones, Khanna, Temkin, Iglesias and Pothuri report no conflict of interest. All authors contributed equally to this practice statement.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical